These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9916933)

  • 61. The chemotherapeutic drug 5-fluorouracil induces apoptosis in mouse thymocytes in vivo via activation of the CD95(APO-1/Fas) system.
    Eichhorst ST; Müerköster S; Weigand MA; Krammer PH
    Cancer Res; 2001 Jan; 61(1):243-8. PubMed ID: 11196169
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Active transcription of the human FASL/CD95L/TNFSF6 promoter region in T lymphocytes involves chromatin remodeling: role of DNA methylation and protein acetylation suggest distinct mechanisms of transcriptional repression.
    Castellano R; Vire B; Pion M; Quivy V; Olive D; Hirsch I; Van Lint C; Collette Y
    J Biol Chem; 2006 May; 281(21):14719-28. PubMed ID: 16595663
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Expression of CD95 ligand in melanocytic lesions as a diagnostic marker.
    Maeda A; Aragane Y; Tezuka T
    Br J Dermatol; 1998 Aug; 139(2):198-206. PubMed ID: 9767232
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Apoptosis induced in T cells by human neuroblastoma cells: role of Fas ligand.
    Shurin GV; Gerein V; Lotze MT; Barksdale EM
    Nat Immun; 1998; 16(5-6):263-74. PubMed ID: 11061594
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hyperosmolarity triggers CD95 membrane trafficking and sensitizes rat hepatocytes toward CD95L-induced apoptosis.
    Reinehr R; Graf D; Fischer R; Schliess F; Häussinger D
    Hepatology; 2002 Sep; 36(3):602-14. PubMed ID: 12198652
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Differential susceptibility to HIV-GP120-sensitized apoptosis in CD4+ T-cell clones with different T-helper phenotypes: role of CD95/CD95L interactions.
    Accornero P; Radrizzani M; Delia D; Gerosa F; Kurrle R; Colombo MP
    Blood; 1997 Jan; 89(2):558-69. PubMed ID: 9002959
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Up-regulation of c-FLIPshort and reduction of activation-induced cell death in CD28-costimulated human T cells.
    Kirchhoff S; Müller WW; Li-Weber M; Krammer PH
    Eur J Immunol; 2000 Oct; 30(10):2765-74. PubMed ID: 11069056
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Expression of Fas and Fas ligand on spleen T cells of experimental animals after unmodified or leukoreduced allogeneic blood transfusions.
    Hashimoto MN; Kimura EY; Yamamoto M; Bordin JO
    Transfusion; 2004 Feb; 44(2):158-63. PubMed ID: 14962305
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Structure/function analysis of the murine CD95L promoter reveals the identification of a novel transcriptional repressor and functional CD28 response element.
    Crist SA; Griffith TS; Ratliff TL
    J Biol Chem; 2003 Sep; 278(38):35950-8. PubMed ID: 12855690
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Novel Egr/NF-AT composite sites mediate activation of the CD95 (APO-1/Fas) ligand promoter in response to T cell stimulation.
    Li-Weber M; Laur O; Krammer PH
    Eur J Immunol; 1999 Sep; 29(9):3017-27. PubMed ID: 10508276
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Immunohistochemical analysis of CD30-positive lymphoproliferative disorders for expression of CD95 and CD95L.
    Sigel JE; Hsi ED
    Mod Pathol; 2000 Apr; 13(4):446-51. PubMed ID: 10786813
    [TBL] [Abstract][Full Text] [Related]  

  • 72. CD4+ T cells inhibit growth of Epstein-Barr virus-transformed B cells through CD95-CD95 ligand-mediated apoptosis.
    Wilson AD; Redchenko I; Williams NA; Morgan AJ
    Int Immunol; 1998 Aug; 10(8):1149-57. PubMed ID: 9723701
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Induction of Fas ligand (CD95L) by the toxic mistletoe lectins in human lymphocytes.
    Büssing A; Stein GM; Pfüller U; Schietzel M
    Anticancer Res; 1999; 19(3A):1785-90. PubMed ID: 10470116
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A novel AP-1 element in the CD95 ligand promoter is required for induction of apoptosis in hepatocellular carcinoma cells upon treatment with anticancer drugs.
    Eichhorst ST; Müller M; Li-Weber M; Schulze-Bergkamen H; Angel P; Krammer PH
    Mol Cell Biol; 2000 Oct; 20(20):7826-37. PubMed ID: 11003676
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Resistance of chimpanzee T cells to human immunodeficiency virus type 1 Tat-enhanced oxidative stress and apoptosis.
    Ehret A; Westendorp MO; Herr I; Debatin KM; Heeney JL; Frank R; Krammer PH
    J Virol; 1996 Sep; 70(9):6502-7. PubMed ID: 8709290
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cytoplasmic overexpression of CD95L in esophageal adenocarcinoma cells overcomes resistance to CD95-mediated apoptosis.
    Watson GA; Naran S; Zhang X; Stang MT; Queiroz de Oliveira PE; Hughes SJ
    Neoplasia; 2011 Mar; 13(3):198-205. PubMed ID: 21390183
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Immune evasion by tumours: involvement of the CD95 (APO-1/Fas) system and its clinical implications.
    Strand S; Galle PR
    Mol Med Today; 1998 Feb; 4(2):63-8. PubMed ID: 9547792
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts.
    Allison J; Georgiou HM; Strasser A; Vaux DL
    Proc Natl Acad Sci U S A; 1997 Apr; 94(8):3943-7. PubMed ID: 9108084
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Characterization of daunorubicin-induced apoptosis in retinal pigment epithelial cells: modulation by CD95L.
    Hueber A; Weller M; Welsandt G; Kociok N; Kirchhof B; Esser P
    Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):2851-7. PubMed ID: 12824222
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Signaling active CD95 receptor molecules trigger co-translocation of inactive CD95 molecules into lipid rafts.
    Lang I; Fick A; Schäfer V; Giner T; Siegmund D; Wajant H
    J Biol Chem; 2012 Jul; 287(28):24026-42. PubMed ID: 22645131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.